Cargando…

Divergent Transcriptomic Effects of Allopregnanolone in Postpartum Depression

Brexanolone, a formulation of the neurosteroid allopregnanolone (ALLO), is approved for treating postpartum depression (PPD) and is being investigated for therapeutic efficacy across numerous neuropsychiatric disorders. Given ALLO’s beneficial effects on mood in women with PPD compared to healthy co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rudzinskas, Sarah A., Mazzu, Maria A., Schiller, Crystal Edler, Meltzer-Brody, Samantha, Rubinow, David R., Schmidt, Peter J., Goldman, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298697/ https://www.ncbi.nlm.nih.gov/pubmed/37372414 http://dx.doi.org/10.3390/genes14061234

Ejemplares similares

Allopregnanolone in postpartum depression: Role in pathophysiology and treatment
por: Meltzer-Brody, Samantha, et al.
Publicado: (2020)

Allopregnanolone in Postpartum Depression
por: Pinna, Graziano, et al.
Publicado: (2022)

SUN-197 Differential Gene Expression in Response to Estradiol Withdrawal in Perimenopausal Depression
por: Rudzinskas, Sarah, et al.
Publicado: (2019)

In vitro model of perimenopausal depression implicates steroid metabolic and proinflammatory genes
por: Rudzinskas, Sarah, et al.
Publicado: (2020)

Transcriptome-wide association study for postpartum depression implicates altered B-cell activation and insulin resistance
por: Guintivano, Jerry, et al.
Publicado: (2022)

Open‐label, proof‐of‐concept study of brexanolone in the treatment of severe postpartum depression
por: Kanes, Stephen J., et al.
Publicado: (2017)

Altered estradiol-dependent cellular Ca(2+) homeostasis and endoplasmic reticulum stress response in Premenstrual Dysphoric Disorder
por: Li, Howard J., et al.
Publicado: (2021)

New insights into perinatal depression: pathogenesis and treatment during pregnancy and postpartum
por: Meltzer-Brody, Samantha
Publicado: (2011)

Allopregnanolone-based treatments for postpartum depression: Why/how do they work?
por: Walton, Najah, et al.
Publicado: (2019)

Cross-continental collaboration for understanding postpartum major depression with psychotic features
por: Kimmel, Mary, et al.
Publicado: (2022)

The Role of Allopregnanolone in Pregnancy in Predicting Postpartum Anxiety Symptoms
por: Osborne, Lauren M., et al.
Publicado: (2019)

Interpersonal therapy versus antidepressant medication for treatment of postpartum depression and anxiety among women with HIV in Zambia: a randomized feasibility trial
por: Spelke, M. Bridget, et al.
Publicado: (2022)

Review of Allopregnanolone Agonist Therapy for the Treatment of Depressive Disorders
por: Walkery, Autumn, et al.
Publicado: (2021)

App-Based Ecological Momentary Assessment to Enhance Clinical Care for Postpartum Depression: Pilot Acceptability Study
por: Krohn, Holly, et al.
Publicado: (2022)

Brexanolone in Postpartum Depression: Post Hoc Analyses to Help Inform Clinical Decision-Making
por: Gerbasi, Margaret E., et al.
Publicado: (2021)

Preclinical and clinical pharmacology of brexanolone (allopregnanolone) for postpartum depression: a landmark journey from concept to clinic in neurosteroid replacement therapy
por: Reddy, Doodipala Samba, et al.
Publicado: (2023)

Associations between commonly used patient-reported outcome tools in postpartum depression clinical practice and the Hamilton Rating Scale for Depression
por: Gerbasi, Margaret E., et al.
Publicado: (2020)

Trajectories of Allopregnanolone and Allopregnanolone to Progesterone Ratio across the Six Subphases of Menstrual Cycle
por: Hamidovic, Ajna, et al.
Publicado: (2023)

The role of allopregnanolone in depressive-like behaviors: Focus on neurotrophic proteins
por: Almeida, Felipe Borges, et al.
Publicado: (2020)

Allopregnanolone and neurogenesis in the nigrostriatal tract
por: Wang, Jun Ming
Publicado: (2014)

The Role of HPA Axis and Allopregnanolone on the Neurobiology of Major Depressive Disorders and PTSD
por: Almeida, Felipe Borges, et al.
Publicado: (2021)

Exploring Novel Therapeutic Approaches for Depressive Disorders: The Role of Allopregnanolone Agonists
por: Bhatti, Najeeha Ahmad, et al.
Publicado: (2023)

PPD ACT: an app-based genetic study of postpartum depression
por: Guintivano, Jerry, et al.
Publicado: (2018)

Cost-Effectiveness of Brexanolone Versus Selective Serotonin Reuptake Inhibitors for the Treatment of Postpartum Depression in the United States
por: Eldar-Lissai, Adi, et al.
Publicado: (2020)

Allopregnanolone Effects on Inhibition in Hippocampal Parvalbumin Interneurons
por: Lu, Xinguo, et al.
Publicado: (2023)

Neuroregenerative Mechanisms of Allopregnanolone in Alzheimer’s Disease
por: Irwin, Ronald W., et al.
Publicado: (2012)

Biosynthesis and biological action of pineal allopregnanolone
por: Tsutsui, Kazuyoshi, et al.
Publicado: (2014)

Allopregnanolone: An overview on its synthesis and effects
por: Diviccaro, Silvia, et al.
Publicado: (2021)

Effect of Zuranolone vs Placebo in Postpartum Depression: A Randomized Clinical Trial
por: Deligiannidis, Kristina M., et al.
Publicado: (2021)

Genome-wide gene expression changes in postpartum depression point towards an altered immune landscape
por: Mehta, Divya, et al.
Publicado: (2021)

Allopregnanolone and neuroinflammation: a focus on multiple sclerosis
por: Noorbakhsh, Farshid, et al.
Publicado: (2014)

Allopregnanolone: Regenerative therapeutic to restore neurological health
por: Hernandez, Gerson D., et al.
Publicado: (2022)

Non-sedative cortical EEG signatures of allopregnanolone and functional comparators
por: Lambert, Peter M., et al.
Publicado: (2022)

Analgesic strategies aimed at stimulating the endogenous production of allopregnanolone
por: Poisbeau, Pierrick, et al.
Publicado: (2014)

Allopregnanolone Enhances GABAergic Inhibition in Spinal Motor Networks
por: Drexler, Berthold, et al.
Publicado: (2020)

Neuroprotective actions of cerebellar and pineal allopregnanolone on Purkinje cells
por: Tsutsui, Kazuyoshi, et al.
Publicado: (2020)

Allopregnanolone: Metabolism, Mechanisms of Action, and Its Role in Cancer
por: Zamora-Sánchez, Carmen J., et al.
Publicado: (2022)

First‐in‐man allopregnanolone use in super‐refractory status epilepticus
por: Vaitkevicius, Henrikas, et al.
Publicado: (2017)

Allopregnanolone preferentially induces energy‐rich food intake in male Wistar rats
por: Holmberg, Ellinor, et al.
Publicado: (2014)

Pleiotropic actions of allopregnanolone underlie therapeutic benefits in stress-related disease
por: Boero, Giorgia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4dq6plhkrtuuk5bo441tm8cir5